|Bid||0.00 x 800|
|Ask||166.45 x 900|
|Day's Range||156.67 - 160.16|
|52 Week Range||132.24 - 243.52|
|Beta (5Y Monthly)||0.52|
|PE Ratio (TTM)||25.65|
|Earnings Date||Jan 24, 2024 - Jan 29, 2024|
|Forward Dividend & Yield||1.92 (1.22%)|
|Ex-Dividend Date||Nov 08, 2023|
|1y Target Est||178.38|
Subscribe to Yahoo Finance Plus to view Fair Value for RMD
ResMed Inc (NYSE:RMD), a global leader in the development, manufacturing, and marketing of innovative medical products for the treatment and management of respiratory disorders, with a focus on sleep-disordered breathing, has recently witnessed a significant insider sell by its Chief Financial Officer (CFO), Brett Sandercock.
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...
The company recently laid off 5% of its staff and stopped certain projects to lower operating costs.